Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Dienogest 2.0 mg Tablets
NCT04230083Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Dec 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dienogest in endometriosis (2 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area under the plasma concentration-time curve from time zero to 72 hours, Area under the plasma concentration-time curve from time zero to time t and 2 more. Started Dec 2019; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT04230083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04230083.